Effectiveness of Resective Surgery in Complex Ameloblastoma of the Jaws: A Retrospective Multicenter Observational Study.
Davide SozziAndrea CassoniElena De PontiMattia MorettiResi PucciDavide SpadoniGabriele CanziGiorgio NovelliValentino ValentiniPublished in: Cancers (2022)
Ameloblastoma is a rare, benign, odontogenic tumor of epithelial origin, characterized by locally aggressive, expansive growth. Treatment is controversial due to the risk of relapse. The aim of this multicenter retrospective study was to evaluate the effectiveness of complete resection in cases of complex ameloblastoma , which is considered at a higher risk of recurrence. Patients who met at least one of these criteria were included: recurrence, soft-tissue involvement, complete erosion of internal/external cortical walls with involvement of the inferior margin of the mandible, and invasion of the maxillary sinus or nasal cavity. Demographic data, tumor site, type of surgery, histological features, and follow-up information were collected for each patient. The cohort included 55 patients with a mean follow-up of 108 ± 66 months. A multivariate logistic model was used to evaluate variables independently associated with relapse. There were six soft-tissue or maxillary sinus relapses, with a recurrence rate of 10.9%. Most of them arose in patients previously treated. The statistical analysis identified the maxillary location as a fundamental relapse risk factor. En bloc resection with large surgical safety margins seemed to be effective in preventing the relapses. However, complete resection was less effective in preventing recurrences in the soft tissues or maxillary sinus.
Keyphrases
- free survival
- soft tissue
- cone beam computed tomography
- minimally invasive
- end stage renal disease
- coronary artery bypass
- randomized controlled trial
- systematic review
- newly diagnosed
- ejection fraction
- risk factors
- chronic kidney disease
- gene expression
- surgical site infection
- peritoneal dialysis
- cross sectional
- case report
- double blind
- clinical trial
- coronary artery disease
- electronic health record
- machine learning
- big data
- data analysis
- cell migration
- acute coronary syndrome